Differential host responses by the type I and III interferons in primary differentiated human nasal epithelial cells are a determinant of antiviral activity
Frontiers in Pharmacology · 15.09.2026 · 17
DOI: 10.3389/fphar.2026.1895412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 15.09.2026. Verfasst von Douglas Jie Wen Tay und 3 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National Univers…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University Health System, National Medical Research Council.
Abstract (Originalsprache)
Background
The interferon (IFN) response is a crucial innate antiviral defence mechanism at the airway epithelium. The epithelial IFN response is predominantly mediated by the type I (IFN-β1) and III (IFN-λ) IFNs, which activate a transcriptional program expressing antiviral and inflammatory genes. Type III IFNs have been purported to be less inflammatory than type I IFN, but exhibit reduced potency. As both type I and III IFNs exert broad antiviral functions, there has been considerable interest in harnessing them as antiviral therapeutics. A better understanding of the effects of exogenous IFN on the host may enable its safer utilisation and prevent unwanted effects in clinical settings. Few studies have compared their potency using a standardised concentration or on primary human cells.
Methods
Here, using differentiated primary human nasal epithelial cell (hNEC) cultures grown at the air-liquid interface, we compared the transcriptional profiles upon exogenous treatment (25 ng/mL) with IFN-β1 and IFN-λ1, -λ2, -λ3, and -λ4 across three time points (6 h, 24 h, and 72 h) by RNA-sequencing. Additionally, we investigated how the apicobasal polarity of the differentiated nasal epithelial influences IFN response by compartmentalised (apical vs. basal) treatment.
Results
Our results revealed that the IFN response is weakly stimulated upon apical IFN treatment and requires additional basal treatment to mount an efficient antiviral response. Upon supplemental basal IFN treatment, IFN-β1 activates a robust transcriptional program of thousands of genes, of which the top differentially expressed genes are involved in the antiviral response and inflammatory pathways. The type III IFNs resulted in fewer genes (hundreds); amongst the type III IFNs, IFN-λ1 and -λ3 had comparable transcriptional profiles, followed by IFN-λ2. IFN-λ4 did not activate the IFN response at the tested concentration. Prophylactic treatment of hNECs with IFN-β1 or IFN-λ1 during influenza A infection demonstrated dose dependent antiviral properties, with IFN-β1 showing superior potency.
Conclusion
Taken together, our study highlights the potency of type I IFN in antiviral control and provides a global IFN transcriptional profile in a physiologically relevant model that could serve as a fundamental framework of the type I and III IFN host response.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Diseases Translational Research Programme and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- NUSMed Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore, Singapore.
- Laboratory of Molecular RNA Virology and Antiviral Strategies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Förderung
- National University Health System
- National Medical Research Council
Zitieren
APA
Tay, D. J. W., Tay, H. Y., Chu, J. J. H., & Tan, K. S. (2026). Differential host responses by the type I and III interferons in primary differentiated human nasal epithelial cells are a determinant of antiviral activity. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1895412
Vancouver
Tay DJW, Tay HY, Chu JJH, Tan KS. Differential host responses by the type I and III interferons in primary differentiated human nasal epithelial cells are a determinant of antiviral activity. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1895412
BibTeX
@article{Tay2026,
author = {Tay, Douglas Jie Wen and Tay, Hui Yi and Chu, Justin Jang Hann and Tan, Kai Sen},
title = {Differential host responses by the type I and III interferons in primary differentiated human nasal epithelial cells are a determinant of antiviral activity},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1895412}
}
EUVIMED